BioSpace News Archive

bluebird bio, Inc. (Nasdaq: BLUE) and Novo Nordisk A/S (NVO) today announced that they have entered into a research collaboration to jointly develop next-generation in vivo genome editing treatments for genetic diseases, including haemophilia.

ChemistryRx proudly introduces an innovative solution to getting kids to take daily topical medications when they have a chronic skin condition: GlitteRx and SupeRx.

A conference call for investors will begin at 8:30 a.m. Eastern Time.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold sponsor at the EUROSPINE 2019 Annual Meeting held October 16-18, 2019 in Helsinki, Finland.

The total installed base of devices with Artificial Intelligence (AI) will grow from 2.7 billion in 2019 to 4.5 billion in 2024, forecasts global tech market advisory firm, ABI Research.

The Company will host a conference call and live webcast with the investment community at 8:30 a.m., Eastern Time on November 6, 2019.

Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CTFH), taking on previously undruggable targets.

The newly launched AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), along with findings from the AAO IRIS® (Intelligent Research in Sight) Registry, will be part of the scientific program.

Amid significant progress to celebrate, the global demand for eye care is set to triple over the next three decades

World Cord Blood Day (November 15th, 2019) is a free event and open to the public. In addition to events worldwide, World Cord Blood Day will feature a free online conference.